vs
Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and JFrog Ltd (FROG). Click either name above to swap in a different company.
CROSS COUNTRY HEALTHCARE INC is the larger business by last-quarter revenue ($236.8M vs $145.3M, roughly 1.6× JFrog Ltd). JFrog Ltd runs the higher net margin — -10.5% vs -35.0%, a 24.6% gap on every dollar of revenue. On growth, JFrog Ltd posted the faster year-over-year revenue change (25.2% vs -23.6%). JFrog Ltd produced more free cash flow last quarter ($49.9M vs $16.1M). Over the past eight quarters, JFrog Ltd's revenue compounded faster (20.4% CAGR vs -21.0%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
JFrog Ltd is a global DevOps technology provider that delivers end-to-end software release, artifact management, and security solutions. It serves clients across tech, finance, retail, and manufacturing sectors, helping teams streamline development and delivery workflows for cloud, on-premises, and hybrid infrastructure.
CCRN vs FROG — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $236.8M | $145.3M |
| Net Profit | $-82.9M | $-15.2M |
| Gross Margin | — | 77.9% |
| Operating Margin | -30.2% | -14.7% |
| Net Margin | -35.0% | -10.5% |
| Revenue YoY | -23.6% | 25.2% |
| Net Profit YoY | -2109.7% | 34.4% |
| EPS (diluted) | $-2.56 | $-0.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $236.8M | $145.3M | ||
| Q3 25 | $250.1M | $136.9M | ||
| Q2 25 | $274.1M | $127.2M | ||
| Q1 25 | $293.4M | $122.4M | ||
| Q4 24 | $309.9M | $116.1M | ||
| Q3 24 | $315.1M | $109.1M | ||
| Q2 24 | $339.8M | $103.0M | ||
| Q1 24 | $379.2M | $100.3M |
| Q4 25 | $-82.9M | $-15.2M | ||
| Q3 25 | $-4.8M | $-16.4M | ||
| Q2 25 | $-6.7M | $-21.7M | ||
| Q1 25 | $-490.0K | $-18.5M | ||
| Q4 24 | $-3.8M | $-23.2M | ||
| Q3 24 | $2.6M | $-22.9M | ||
| Q2 24 | $-16.1M | $-14.3M | ||
| Q1 24 | $2.7M | $-8.8M |
| Q4 25 | — | 77.9% | ||
| Q3 25 | 20.4% | 77.4% | ||
| Q2 25 | 20.4% | 76.3% | ||
| Q1 25 | 20.0% | 75.3% | ||
| Q4 24 | — | 75.4% | ||
| Q3 24 | 20.4% | 75.0% | ||
| Q2 24 | 20.8% | 78.8% | ||
| Q1 24 | 20.4% | 79.5% |
| Q4 25 | -30.2% | -14.7% | ||
| Q3 25 | -2.4% | -15.8% | ||
| Q2 25 | -2.1% | -20.4% | ||
| Q1 25 | -0.3% | -18.8% | ||
| Q4 24 | -1.1% | -21.9% | ||
| Q3 24 | 0.9% | -27.4% | ||
| Q2 24 | -5.7% | -18.6% | ||
| Q1 24 | 0.8% | -16.6% |
| Q4 25 | -35.0% | -10.5% | ||
| Q3 25 | -1.9% | -12.0% | ||
| Q2 25 | -2.4% | -17.0% | ||
| Q1 25 | -0.2% | -15.1% | ||
| Q4 24 | -1.2% | -20.0% | ||
| Q3 24 | 0.8% | -21.0% | ||
| Q2 24 | -4.7% | -13.9% | ||
| Q1 24 | 0.7% | -8.8% |
| Q4 25 | $-2.56 | $-0.13 | ||
| Q3 25 | $-0.15 | $-0.14 | ||
| Q2 25 | $-0.20 | $-0.19 | ||
| Q1 25 | $-0.02 | $-0.16 | ||
| Q4 24 | $-0.13 | $-0.21 | ||
| Q3 24 | $0.08 | $-0.21 | ||
| Q2 24 | $-0.47 | $-0.13 | ||
| Q1 24 | $0.08 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $108.7M | $704.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $322.8M | $887.4M |
| Total Assets | $449.0M | $1.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $108.7M | $704.4M | ||
| Q3 25 | $99.1M | $651.1M | ||
| Q2 25 | $81.2M | $611.7M | ||
| Q1 25 | $80.7M | $563.5M | ||
| Q4 24 | $81.6M | $522.0M | ||
| Q3 24 | $64.0M | $467.8M | ||
| Q2 24 | $69.6M | $591.3M | ||
| Q1 24 | $5.2M | $579.6M |
| Q4 25 | $322.8M | $887.4M | ||
| Q3 25 | $408.1M | $859.4M | ||
| Q2 25 | $412.2M | $826.5M | ||
| Q1 25 | $418.2M | $800.0M | ||
| Q4 24 | $419.0M | $773.5M | ||
| Q3 24 | $424.7M | $756.2M | ||
| Q2 24 | $433.3M | $721.4M | ||
| Q1 24 | $462.4M | $707.8M |
| Q4 25 | $449.0M | $1.3B | ||
| Q3 25 | $538.2M | $1.3B | ||
| Q2 25 | $553.8M | $1.2B | ||
| Q1 25 | $576.2M | $1.2B | ||
| Q4 24 | $589.3M | $1.1B | ||
| Q3 24 | $597.4M | $1.1B | ||
| Q2 24 | $602.9M | $1.0B | ||
| Q1 24 | $648.4M | $997.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.2M | $50.7M |
| Free Cash FlowOCF − Capex | $16.1M | $49.9M |
| FCF MarginFCF / Revenue | 6.8% | 34.3% |
| Capex IntensityCapex / Revenue | 0.9% | 0.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $40.1M | $142.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.2M | $50.7M | ||
| Q3 25 | $20.1M | $30.2M | ||
| Q2 25 | $4.2M | $36.1M | ||
| Q1 25 | $5.7M | $28.8M | ||
| Q4 24 | $24.2M | $49.1M | ||
| Q3 24 | $7.5M | $27.6M | ||
| Q2 24 | $82.4M | $16.7M | ||
| Q1 24 | $6.0M | $17.5M |
| Q4 25 | $16.1M | $49.9M | ||
| Q3 25 | $17.9M | $28.8M | ||
| Q2 25 | $2.3M | $35.5M | ||
| Q1 25 | $3.8M | $28.1M | ||
| Q4 24 | $21.7M | $48.5M | ||
| Q3 24 | $6.3M | $26.7M | ||
| Q2 24 | $79.6M | $16.0M | ||
| Q1 24 | $3.8M | $16.6M |
| Q4 25 | 6.8% | 34.3% | ||
| Q3 25 | 7.2% | 21.0% | ||
| Q2 25 | 0.8% | 27.9% | ||
| Q1 25 | 1.3% | 23.0% | ||
| Q4 24 | 7.0% | 41.8% | ||
| Q3 24 | 2.0% | 24.5% | ||
| Q2 24 | 23.4% | 15.5% | ||
| Q1 24 | 1.0% | 16.6% |
| Q4 25 | 0.9% | 0.6% | ||
| Q3 25 | 0.9% | 1.0% | ||
| Q2 25 | 0.7% | 0.5% | ||
| Q1 25 | 0.6% | 0.5% | ||
| Q4 24 | 0.8% | 0.5% | ||
| Q3 24 | 0.4% | 0.9% | ||
| Q2 24 | 0.8% | 0.7% | ||
| Q1 24 | 0.6% | 0.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.92× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 2.23× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
FROG
Segment breakdown not available.
